Immunotherapy in cervical cancer: the advent of precision medicine

Department of Radiotherapy, Policlinico Umberto I, “Sapienza” University of Rome, Rome, Italy; Department of Woman and Child Sciences, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy; Catholic University of the Sacred Heart, Rome, Italy Correspondence to: Dr. Claudia Marchetti. Department of Woman and Child Sciences, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy. Email: clamarchetti81@gmail.com. Provenance: This is an invited article commissioned by the Editorial Office, Annals of Translational Medicine. Comment on: Chung HC, Ros W, Delord JP, et al. Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study. J Clin Oncol 2019;37:1470-8.